BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 27422818)

  • 1. The Lipidated Peptidomimetic Lau-((S)-Aoc)-(Lys-βNphe)6-NH2 Is a Novel Formyl Peptide Receptor 2 Agonist That Activates Both Human and Mouse Neutrophil NADPH Oxidase.
    Holdfeldt A; Skovbakke SL; Winther M; Gabl M; Nielsen C; Perez-Gassol I; Larsen CJ; Wang JM; Karlsson A; Dahlgren C; Forsman H; Franzyk H
    J Biol Chem; 2016 Sep; 291(38):19888-99. PubMed ID: 27422818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The proteolytically stable peptidomimetic Pam-(Lys-βNSpe)6-NH2 selectively inhibits human neutrophil activation via formyl peptide receptor 2.
    Skovbakke SL; Heegaard PM; Larsen CJ; Franzyk H; Forsman H; Dahlgren C
    Biochem Pharmacol; 2015 Jan; 93(2):182-95. PubMed ID: 25462815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining Elements from Two Antagonists of Formyl Peptide Receptor 2 Generates More Potent Peptidomimetic Antagonists.
    Skovbakke SL; Holdfeldt A; Nielsen C; Hansen AM; Perez-Gassol I; Dahlgren C; Forsman H; Franzyk H
    J Med Chem; 2017 Aug; 60(16):6991-6997. PubMed ID: 28700225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The peptidomimetic Lau-(Lys-βNSpe)
    Skovbakke SL; Winther M; Gabl M; Holdfeldt A; Linden S; Wang JM; Dahlgren C; Franzyk H; Forsman H
    Biochem Pharmacol; 2016 Nov; 119():56-65. PubMed ID: 27614010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional and signaling characterization of the neutrophil FPR2 selective agonist Act-389949.
    Lind S; Sundqvist M; Holmdahl R; Dahlgren C; Forsman H; Olofsson P
    Biochem Pharmacol; 2019 Aug; 166():163-173. PubMed ID: 31085160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FPR2 signaling without β-arrestin recruitment alters the functional repertoire of neutrophils.
    Gabl M; Holdfeldt A; Sundqvist M; Lomei J; Dahlgren C; Forsman H
    Biochem Pharmacol; 2017 Dec; 145():114-122. PubMed ID: 28855087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pepducin derived from the third intracellular loop of FPR2 is a partial agonist for direct activation of this receptor in neutrophils but a full agonist for cross-talk triggered reactivation of FPR2.
    Gabl M; Winther M; Skovbakke SL; Bylund J; Dahlgren C; Forsman H
    PLoS One; 2014; 9(10):e109516. PubMed ID: 25303226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The FPR2-specific ligand MMK-1 activates the neutrophil NADPH-oxidase, but triggers no unique pathway for opening of plasma membrane calcium channels.
    Karlsson J; Stenfeldt AL; Rabiet MJ; Bylund J; Forsman HF; Dahlgren C
    Cell Calcium; 2009 May; 45(5):431-8. PubMed ID: 19282028
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Sundqvist M; Christenson K; Gabl M; Holdfeldt A; Jennbacken K; Møller TC; Dahlgren C; Forsman H
    J Immunol; 2019 Dec; 203(12):3349-3360. PubMed ID: 31694908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stable formyl peptide receptor agonists that activate the neutrophil NADPH-oxidase identified through screening of a compound library.
    Forsman H; Kalderén C; Nordin A; Nordling E; Jensen AJ; Dahlgren C
    Biochem Pharmacol; 2011 Feb; 81(3):402-11. PubMed ID: 21095183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What formyl peptide receptors, if any, are triggered by compound 43 and lipoxin A4?
    Forsman H; Önnheim K; Andreasson E; Dahlgren C
    Scand J Immunol; 2011 Sep; 74(3):227-234. PubMed ID: 21535079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barbadin selectively modulates FPR2-mediated neutrophil functions independent of receptor endocytosis.
    Sundqvist M; Holdfeldt A; Wright SC; Møller TC; Siaw E; Jennbacken K; Franzyk H; Bouvier M; Dahlgren C; Forsman H
    Biochim Biophys Acta Mol Cell Res; 2020 Dec; 1867(12):118849. PubMed ID: 32916203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrin-releasing peptide/neuromedin B receptor antagonists PD176252, PD168368, and related analogs are potent agonists of human formyl-peptide receptors.
    Schepetkin IA; Kirpotina LN; Khlebnikov AI; Jutila MA; Quinn MT
    Mol Pharmacol; 2011 Jan; 79(1):77-90. PubMed ID: 20943772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of BMS-986235/LAR-1219: A Potent Formyl Peptide Receptor 2 (FPR2) Selective Agonist for the Prevention of Heart Failure.
    Asahina Y; Wurtz NR; Arakawa K; Carson N; Fujii K; Fukuchi K; Garcia R; Hsu MY; Ishiyama J; Ito B; Kick E; Lupisella J; Matsushima S; Ohata K; Ostrowski J; Saito Y; Tsuda K; Villarreal F; Yamada H; Yamaoka T; Wexler R; Gordon D; Kohno Y
    J Med Chem; 2020 Sep; 63(17):9003-9019. PubMed ID: 32407089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pepducin designed to modulate P2Y2R function interacts with FPR2 in human neutrophils and transfers ATP to an NADPH-oxidase-activating ligand through a receptor cross-talk mechanism.
    Gabl M; Holdfeldt A; Winther M; Oprea T; Bylund J; Dahlgren C; Forsman H
    Biochim Biophys Acta; 2016 Jun; 1863(6 Pt A):1228-37. PubMed ID: 26996596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formyl peptide derived lipopeptides disclose differences between the receptors in mouse and men and call the pepducin concept in question.
    Winther M; Holdfeldt A; Sundqvist M; Rajabkhani Z; Gabl M; Bylund J; Dahlgren C; Forsman H
    PLoS One; 2017; 12(9):e0185132. PubMed ID: 28934373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biased allosteric modulation of formyl peptide receptor 2 leads to distinct receptor conformational states for pro- and anti-inflammatory signaling.
    Zhang S; Gong H; Ge Y; Ye RD
    Pharmacol Res; 2020 Nov; 161():105117. PubMed ID: 32768626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Two Formyl Peptide Receptors Differently Regulate GPR84-Mediated Neutrophil NADPH Oxidase Activity.
    Mårtensson J; Sundqvist M; Manandhar A; Ieremias L; Zhang L; Ulven T; Xie X; Björkman L; Forsman H
    J Innate Immun; 2021; 13(4):242-256. PubMed ID: 33789297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional selective FPR1 signaling in favor of an activation of the neutrophil superoxide generating NOX2 complex.
    Lind S; Dahlgren C; Holmdahl R; Olofsson P; Forsman H
    J Leukoc Biol; 2021 Jun; 109(6):1105-1120. PubMed ID: 33040403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The leukocyte chemotactic receptor FPR2, but not the closely related FPR1, is sensitive to cell-penetrating pepducins with amino acid sequences descending from the third intracellular receptor loop.
    Forsman H; Bylund J; Oprea TI; Karlsson A; Boulay F; Rabiet MJ; Dahlgren C
    Biochim Biophys Acta; 2013 Aug; 1833(8):1914-23. PubMed ID: 23562731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.